Christopher Kepler, MD
Orthopaedic Surgery · Philadelphia, PANPI 1114184389
Payments from drug & device makers
Across 54 payments — averaging $1515.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgalign Spine Technologies, Inc.$35K
- Curiteva, Inc.$19K
- Pfizer$15K
- Pioneer Surgical Technology, Inc.$8K
- RTI Surgical, Inc$2K
- Zimmer Biomet$944
- plus $2K from 12 others
What the payments were for
- Royalty or licence$18,07558%
- Travel & lodging$1,3324%
- Food & beverage$2,6859%
- Charitable contribution$9,32030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgalign Spine Technologies, Inc. | 11 | $35,322 |
| Curiteva, Inc. | 2 | $18,629 |
| Pfizer | 7 | $15,197 |
| Pioneer Surgical Technology, Inc. | 2 | $7,701 |
| RTI Surgical, Inc | 1 | $1,619 |
| Zimmer Biomet | 7 | $944 |
| Stryker | 11 | $576 |
| Globus Medical | 2 | $565 |
| The Institute Of Musculoskeletal Science And Education | 1 | $527 |
| Icotec Medical Inc. | 1 | $153 |
| Highridge Medical LLC | 1 | $136 |
| Seaspine Orthopedics Corporation | 1 | $116 |
| Johnson & Johnson | 2 | $105 |
| Kuros Biosciences USA, Inc | 1 | $96 |
| Carbofix Spine Inc | 1 | $93 |
| Liberty Surgical Inc. | 1 | $33 |
| Bioventus LLC | 1 | $22 |
| Heraeus Medical, LLC. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Forte$7,701
- FORTILINK$1,619
- Lapidus Plate$761
- Orthros$527
- ExcelsiusGPS Robotic Navigation System$437
- EVEREST SPINAL SYSTEM$170
- icotec BlackArmor Spine System$153
- MOBI-C PLUG & FIT US$136
- Excelsius - GPS$128
- Cambria NanoMetalene$116
- NONE$111
How this compares
$81,859 in reported general payments places this provider in the 90th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 124 | $1,607 |
| Methylprednisolone | 169 | $947 |
| Tizanidine Hcl | 64 | $537 |
| Cyclobenzaprine Hcl | 37 | $311 |
| Celecoxib | 14 | $244 |
| Naproxen | 32 | $206 |
| Baclofen | 21 | $128 |
| Meloxicam | 12 | $125 |
| Cephalexin | 17 | $118 |
| Prednisone | 17 | $48 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Philadelphia
- John FenlinPhiladelphia$5.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$4.1M
- Samir MehtaPhiladelphia$3.7M
- Surena NamdariPhiladelphia$1.8M
- Craig IsraelitePhiladelphia$938K
- Andrew KuntzPhiladelphia$732K
- Neil ShethPhiladelphia$633K
- Vahid EntezariPhiladelphia$487K
- Amrit KhalsaPhiladelphia$475K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.